pre-ipo
Stage
About
Beam Therapeutics Inc develops precision genetic medicines using base editing technology to treat serious diseases by correcting point mutations in DNA.
Explore Beam Therapeutics Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.